HomeCompareNXSL vs CL

NXSL vs CL: Dividend Comparison 2026

NXSL yields 30303.03% · CL yields 2.44%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NXSL wins by $3.263808061549561e+21M in total portfolio value
10 years
NXSL
NXSL
● Live price
30303.03%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$3.263808061549561e+21M
Annual income
$3,242,757,379,434,520,500,000,000,000.00
Full NXSL calculator →
CL
CL
● Live price
2.44%
Share price
$85.23
Annual div
$2.08
5Y div CAGR
28.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$41.0K
Annual income
$5,451.69
Full CL calculator →

Portfolio growth — NXSL vs CL

📍 NXSL pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNXSLCL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NXSL + CL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NXSL pays
CL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NXSL
Annual income on $10K today (after 15% tax)
$2,575,757.58/yr
After 10yr DRIP, annual income (after tax)
$2,756,343,772,519,342,000,000,000,000.00/yr
CL
Annual income on $10K today (after 15% tax)
$207.44/yr
After 10yr DRIP, annual income (after tax)
$4,633.94/yr
At 15% tax rate, NXSL beats the other by $2,756,343,772,519,342,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NXSL + CL for your $10,000?

NXSL: 50%CL: 50%
100% CL50/50100% NXSL
Portfolio after 10yr
$1.6319040307747805e+21M
Annual income
$1,621,378,689,717,260,200,000,000,000.00/yr
Blended yield
99.36%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on CL right now

NXSL
No analyst data
CL
Analyst Ratings
17
Buy
24
Hold
2
Sell
Consensus: Hold
Price Target
$92.45
+8.5% upside vs current
Range: $85.00 — $100.00
Altman Z
4.5
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NXSL buys
0
CL buys
9
PoliticianChamberTickerTypeAmountDate
John Boozman🏛 Senate$CL▼ Sell$1,001 - $15,0002025-10-09
Ro Khanna🏢 House$CL▼ Sell$1,001 - $15,0002025-10-07
Rick Larsen🏢 House$CL▼ Sell$1,001 - $15,0002025-10-06
Ro Khanna🏢 House$CL▼ Sell$1,001 - $15,0002025-09-29
Julie Johnson🏢 House$CL▼ Sell$1,001 - $15,0002025-09-25
Lisa McClain🏢 House$CL▼ Sell$1,001 - $15,0002025-09-11
Tim Moore🏢 House$CL▼ Sell$1,001 - $15,0002025-09-10
Ro Khanna🏢 House$CL▲ Buy$1,001 - $15,0002025-09-05
Ro Khanna🏢 House$CL▲ Buy$1,001 - $15,0002025-08-26
Lisa McClain🏢 House$CL▲ Buy$1,001 - $15,0002025-08-13
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNXSLCL
Forward yield30303.03%2.44%
Annual dividend / share$2.00$2.08
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28.6%
Portfolio after 10y$3.263808061549561e+21M$41.0K
Annual income after 10y$3,242,757,379,434,520,500,000,000,000.00$5,451.69
Total dividends collected$3.2624231116646724e+21M$18.1K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: NXSL vs CL ($10,000, DRIP)

YearNXSL PortfolioNXSL Income/yrCL PortfolioCL Income/yrGap
1← crossover$3,041,003$3,030,303.03$11,014$313.84+$3.03MNXSL
2$864,483,845$861,229,971.77$12,200$415.44+$864.47MNXSL
3$229,735,200,804$228,810,203,089.76$13,607$553.09+$229735.19MNXSL
4$57,073,803,532,538$56,827,986,867,677.43$15,301$741.41+$57073803.52MNXSL
5$13,255,411,832,905,296$13,194,342,863,125,480.00$17,374$1,002.00+$13255411832.89MNXSL
6$2,878,100,090,729,619,500$2,863,916,800,068,411,000.00$19,958$1,367.44+$2878100090729.60MNXSL
7$584,230,965,528,377,800,000$581,151,398,431,297,240,000.00$23,243$1,887.87+$584230965528377.88MNXSL
8$110,876,546,219,110,120,000,000$110,251,419,085,994,750,000,000.00$27,512$2,642.43+$110876546219110112.00MNXSL
9$19,673,534,686,953,956,000,000,000$19,554,896,782,499,505,000,000,000.00$33,197$3,759.22+$19673534686953955328.00MNXSL
10$3,263,808,061,549,561,000,000,000,000$3,242,757,379,434,520,500,000,000,000.00$40,973$5,451.69+$3.263808061549561e+21MNXSL

NXSL vs CL: Complete Analysis 2026

NXSLStock

NexTech FAS Technologies, Inc. engages in the design, manufacture, sale, and servicing of high-precision coating systems and advanced metrology and automation solutions for the semiconductor and flat panel display (FPD) industries. It also involves in the development FAS-Coat, a patented extrusion coating technology for aka spinless coating, slot die coating, and slit coating in the manufacturing process of FPD substrates. The company's products include Altair for testing the repeatability of systems that detect particles on the surface of substrates; Aludra, a reticle inspection system that employs light scattering technology to infer the presence of particles on a semiconductor reticle; Orion, a reticle inspection system, which provides inspection for semiconductor reticles and photomasks; FPDStar, an optical inspection system for identifying and mapping pattern, particle, and processing defects on FPD/TFT substrates; and NexTStar, an automated optical inspection system that represents breakthrough performance in FPD pattern, particle, and processing defect detection. Its products also comprise Pegasu, a wafer sorter series that provides standards-compliant user and automation interfaces; Proteus Reticle Load Port Upgrade kit, a hardware and software solution; and PST upgrades for wafer sorters. In addition, the company's FAS-Coat coating systems process substrates for the flat panel display, multi-chip module, solar cell, biomedical, and semiconductor industries. It was formerly known as NexTech Solutions, Inc. and changed its name to NexTech FAS Technologies, Inc. in July 2007. The company is headquartered in Austin, Texas.

Full NXSL Calculator →

CLConsumer Staples

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly to a range of traditional and eCommerce retailers, wholesalers, and distributors. It also includes pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill's Science Diet brand; and a range of therapeutic products to manage disease conditions in dogs and cats under the Hill's Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.

Full CL Calculator →
📬

Get this NXSL vs CL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NXSL vs SCHDNXSL vs JEPINXSL vs ONXSL vs KONXSL vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.